DE3782199T2 - Biologisch aktive peptide tan-866. - Google Patents

Biologisch aktive peptide tan-866.

Info

Publication number
DE3782199T2
DE3782199T2 DE8787109649T DE3782199T DE3782199T2 DE 3782199 T2 DE3782199 T2 DE 3782199T2 DE 8787109649 T DE8787109649 T DE 8787109649T DE 3782199 T DE3782199 T DE 3782199T DE 3782199 T2 DE3782199 T2 DE 3782199T2
Authority
DE
Germany
Prior art keywords
tan
biologically active
active peptide
peptide
biologically
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE8787109649T
Other languages
English (en)
Other versions
DE3782199D1 (de
Inventor
Setsuo Harada
Hideo Ono
Nozomi Katayama
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Takeda Pharmaceutical Co Ltd
Original Assignee
Takeda Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Chemical Industries Ltd filed Critical Takeda Chemical Industries Ltd
Application granted granted Critical
Publication of DE3782199D1 publication Critical patent/DE3782199D1/de
Publication of DE3782199T2 publication Critical patent/DE3782199T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/38—Pseudomonas
    • C12R2001/385—Pseudomonas aeruginosa
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00—Peptide or protein sequence
    • Y10S930/01—Peptide or protein sequence
    • Y10S930/19—Antibiotic
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00—Peptide or protein sequence
    • Y10S930/01—Peptide or protein sequence
    • Y10S930/27—Cyclic peptide or cyclic protein

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • General Engineering & Computer Science (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Oncology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
DE8787109649T 1986-07-08 1987-07-04 Biologisch aktive peptide tan-866. Expired - Fee Related DE3782199T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP16043986 1986-07-08
JP8209587 1987-04-01

Publications (2)

Publication Number Publication Date
DE3782199D1 DE3782199D1 (de) 1992-11-19
DE3782199T2 true DE3782199T2 (de) 1993-02-25

Family

ID=26423115

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8787109649T Expired - Fee Related DE3782199T2 (de) 1986-07-08 1987-07-04 Biologisch aktive peptide tan-866.

Country Status (5)

Country Link
US (1) US4816559A (de)
EP (1) EP0253245B1 (de)
JP (1) JP2640932B2 (de)
CA (1) CA1334287C (de)
DE (1) DE3782199T2 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8817743D0 (en) * 1988-07-26 1988-09-01 Fujisawa Pharmaceutical Co Fr901228 substance & preparation thereof
US11174288B2 (en) 2016-12-06 2021-11-16 Northeastern University Heparin-binding cationic peptide self-assembling peptide amphiphiles useful against drug-resistant bacteria

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1360549A (fr) * 1963-06-14 1964-05-08 Ciba Geigy Les nouvelles substances actives ferricrocine et desferricrocine produites par des souches d'aspergillus, et leurs dérivés, et procédé pour leur préparation

Also Published As

Publication number Publication date
JPS6425795A (en) 1989-01-27
US4816559A (en) 1989-03-28
EP0253245A3 (en) 1990-04-25
EP0253245A2 (de) 1988-01-20
JP2640932B2 (ja) 1997-08-13
CA1334287C (en) 1995-02-07
EP0253245B1 (de) 1992-10-14
DE3782199D1 (de) 1992-11-19

Similar Documents

Publication Publication Date Title
DE3689246D1 (de) Physiologisch aktives Polypeptid BUF-3.
DE3778287D1 (de) Peptidische zusammensetzung.
DE3789413T2 (de) Lymphokin-ähnliche Peptide.
ATE73338T1 (de) Biologisch wirksame kopolymere.
FI875217A0 (fi) Aktivt pansar.
NO870533L (no) Terapeutisk aktive 3-alkoksy-2-aminopropylaminer.
IT1212790B (it) Peptidi biologicamente attivi.
FI841649A0 (fi) Biologiskt aktiva polypeptider.
FI891820A0 (fi) Biologiskt aktiva foereningar.
BR8207789A (pt) Peptidios biologicamente ativos
DE3869939D1 (de) Biologisch wirksame peptide.
IT8620026A0 (it) Tripeptide ad attivita'immunostimolante.
FI883254A0 (fi) Cytostatiskt aktiva antracyklinderivat.
DE3782199D1 (de) Biologisch aktive peptide tan-866.
IT1214444B (it) Peptidi biologicamente attivi.
IT8620027A0 (it) Tripeptide ad attivita'immunostimolante.
DE3780388T2 (de) Fsh-stimulierendes peptid.
NO872386L (no) Peptider.
ATE81531T1 (de) Biologisch aktive peptide tan-866.
DE3787371D1 (de) Biologisch aktives mittel.
FI883253A (fi) Cytostatiskt aktiva antracyklinderivat.
DE3774988D1 (de) Peptidderivate.
NO883008D0 (no) Peptidforbindelser.
FI865365A0 (fi) Biologiska aktiva kopolymerer.
ATE103339T1 (de) Lymphokin-aehnliche peptide.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee